results study participants had on average a diabetes duration of 9 years, a mean hba1c of 6,6% units by mono-s standard and were usually treated with metformin alone (3 subjects) or metformin in combination with a sulfonylurea (3 subjects) or a thiazolidinedione (3 subjects).